FDA Approves Groundbreaking mRNA Brain Cancer Therapy | Philadelphia News

FDA just approved a groundbreaking mRNA therapy that trains the immune system to target and destroy a rare, aggressive brain cancer — offering new hope where few treatments existed before. This precision medicine zeroes in on a unique protein on cancer cells, sparing healthy tissue, and has already shown promise in shrinking tumors and extending survival. Patient advocates and doctors are cautiously optimistic as this milestone, born from years of research and brave trial participants, opens doors for combination therapies and broader use. With ongoing studies and FDA monitoring, this breakthrough underscores the power of science and the urgent need for continued investment in curing devastating diseases. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0be40464384847ab